Sasakawa Leprosy Initiative

What Sasakawa Leprosy Initiative does

Sasakawa Leprosy (Hansen's Disease) Initiative is a non-profit strategic alliance founded in 1975 that links three entities: Yohei Sasakawa in his capacity as WHO Goodwill Ambassador for Leprosy Elimination (appointed 2001), the Sasakawa Health Foundation (SHF), and The Nippon Foundation (TNF). The Initiative is headquartered in Japan, administered by SHF, and pursues a three-pillar mission of tackling disease, eliminating discrimination, and preserving leprosy history. Its primary "products" are advocacy campaigns (the "Don't Forget Leprosy" campaign, the annual Global Appeal launched near World Leprosy Day), publications (the Leprosy Bulletin, handbooks for parliamentarians, the Leprosy Today website), and grantmaking through the SHF grant program in support of NGOs, research institutions, and organizations of persons affected by leprosy (DPOs). Major programs include the Young Scholar Program, country-level conferences, and a growing partnership with Education International.

The underlying technology is non-commercial: WHO-recommended multidrug therapy (MDT) for treatment and single-dose rifampicin as post-exposure prophylaxis for contacts, with the Initiative supporting research into improved diagnostics and transmission interruption. It does not produce or sell products; leprosy medications are distributed free of charge through WHO and national health ministries. The Initiative's "distribution" operates through (a) diplomatic advocacy by the WHO Goodwill Ambassador to heads of state and health ministries in 23 WHO priority countries, (b) grant funding from SHF to partner NGOs and DPOs, (c) global conferences and events (Bergen, Vatican, Bali, Brussels, the 3rd Global Forum of People's Organizations), and (d) freely accessible digital publications and resources.

The business model is philanthropic grantmaking rather than commercial revenue. The Nippon Foundation is the primary funder and has contributed over $200 million USD to WHO for leprosy elimination since 1975, including a $50 million commitment for free MDT (1995–1999) and a $23 million / 10-year commitment announced at the 2025 World Health Assembly (2025–2035). Customer segments span persons affected by leprosy and their families, national health ministries in endemic countries (India, Indonesia, Brazil, Nepal, Sri Lanka, Ethiopia, Angola, Nigeria, Colombia, etc.), and a global ecosystem of DPOs (PerMaTa, APAL, MORHAN, ENAPAL, IDEA Nepal) and implementation NGOs (NLR, ALERT-India, Damien Foundation, Fontilles, YDTI).

Name

Sasakawa Leprosy Initiative

Legal name

Sasakawa Health Foundation

Website

https://sasakawaleprosyinitiative.org

Company type

Private

Founded year

1975

Operating status

Operating

Short description

The Sasakawa Leprosy (Hansen's Disease) Initiative is a non-profit strategic alliance of WHO Goodwill Ambassador Yohei Sasakawa, Sasakawa Health Foundation, and The Nippon Foundation that advocates for zero leprosy across 23+ priority countries through grantmaking, diplomacy, and public health campaigns.

Ownership category

akta.pro rank

Product category

Public Health Advocacy and Grantmaking

NAICS

Voluntary Health Organizations (813212), Human Rights Organizations (813311), Grantmaking and Giving Services (8132), Social Advocacy Organizations (81331)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Social Services (8300)

akta.pro industry

PRIMARYHLAJAKAO

Global Health Advocacy, Policy & Rights Organizations

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

SECONDARYHLAJAOAE

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health Initiatives & Partnerships

SECONDARYHLAJAOAA

Multilateral Global Health Partnerships (UN/WHO-led Initiatives)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health Initiatives & Partnerships

SECONDARYBPAGAFAB

Human Rights & Anti-Discrimination Organizations

Business & Public Services/Nonprofit, NGO & Social Services/Civil Rights, Advocacy & Public Policy Organizations

Keywords

• Leprosy elimination advocacy
• Public health grantmaking
• Hansen's disease programs
• Stigma reduction campaigns
• Multidrug therapy support

Headquarters

HQ city

Akasaka

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Foundation Grants and Philanthropic Funding: The Sasakawa Leprosy (Hansen’s Disease) Initiative is a strategic alliance funded primarily by The Nippon Foundation (TNF) and Sasakawa Health Foundation (SHF). TNF/SHF has contributed over $200 million USD to WHO for leprosy elimination since 1975, including $50 million USD for free MDT distribution (1995–1999). TNF/SHF committed $23 million USD over 10 years at the 2025 World Health Assembly to support WHO's Global Leprosy Program. The Initiative distributes grants to NGOs, research institutions, and organizations of persons affected by leprosy in three focus areas: tackling disease, eliminating discrimination, and preserving history.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

The Sasakawa Leprosy Initiative is a strategic alliance that combines WHO diplomatic advocacy, philanthropic grantmaking, and public awareness campaigning to advance the global elimination of leprosy (Hansen's disease). It funds NGOs, organizations of persons affected by leprosy, and research institutions; runs advocacy campaigns and global events; produces educational publications and digital resources; and supports multidrug therapy (MDT) and post-exposure prophylaxis distribution through WHO and national health systems.

Product overview

Sasakawa Leprosy Initiative is a strategic alliance combining the WHO Goodwill Ambassador for Leprosy Elimination, Sasakawa Health Foundation, and The Nippon Foundation. The organization operates advocacy campaigns (Don't Forget Leprosy), annual events (Global Appeal), publications (Leprosy Bulletin), educational programs (Young Scholar Program), and a grant funding program. The initiative focuses on three pillars: tackling disease, eliminating discrimination, and preserving history. Resources include the Leprosy Today website with photos, interviews, essays, and documentary videos.

Differentiator

Problem solved

Functional benefit

Products and services

• Don't Forget Leprosy Campaign An ongoing global awareness campaign sharing the message that leprosy is curable, medication is free, and discrimination must stop. Includes webinars, advocacy videos, and community events aimed at the public, health professionals, and policymakers.
• Global Appeal An annual flagship event launched on or near World Leprosy Day, supported by individuals and organizations worldwide, calling for an end to marginalization of persons affected by leprosy and the realization of a just and equitable society.
• Sasakawa Health Foundation Grant Program A grant funding program administered by Sasakawa Health Foundation supporting NGOs, DPOs, and research institutions worldwide in three focus areas: tackling disease, eliminating discrimination, and preserving history.
• Leprosy Bulletin A regular publication featuring the WHO Goodwill Ambassador's messages, reports, interviews, viewpoints, and news about leprosy elimination efforts worldwide. Distributed to stakeholders and available on the website.
• Leprosy Today Website A website created by The Nippon Foundation sharing information about leprosy in English, featuring photographs, interviews, essays, and documentary videos from the 2010-2019 period.
• Young Scholar Program An education and engagement program supporting young scholars to engage in leprosy-related research and advocacy work.

Quantifiable outcome

• Since the adoption of multidrug therapy (MDT), around 20 million people have been cured of leprosy.
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

17 partnerships are on record, tiered core and minor.

• Education InternationalcoreStrategic or Co-development Partner · 29 January 2026Education International, a global union federation representing 375 member organizations and over 33 million teachers in 180 countries, co-hosted Global Appeal 2026 with the Sasakawa Leprosy Initiative in Brussels, Belgium. The partnership focuses on the transformative power of education in dispelling leprosy myths, reducing prejudice, and promoting inclusion through schools and educators.
• Damien FoundationcoreStrategic or Co-development Partner · 29 January 2026The Damien Foundation co-partnered with Education International and the Sasakawa Leprosy Initiative for Global Appeal 2026 in Brussels. The Damien Foundation supports leprosy and tuberculosis control programs globally and contributes expertise on the intersection of education and stigma reduction.
• Global Partnership for Zero Leprosy (GPZL)coreStrategic or Co-development PartnerIn 2018, Sasakawa Health Foundation became a founding member of the Global Partnership for Zero Leprosy (GPZL). GPZL aims to facilitate alignment among member organizations to accelerate progress toward zero leprosy — zero disease, zero disability, zero discrimination — through coordinated action.
• University of BergencoreStrategic or Co-development PartnerThe Sasakawa Leprosy Initiative collaborated with the University of Bergen in Norway to organize the Bergen International Conference on Hansen's Disease (June 21–22, 2023) and the Armauer Hansen International Film Festival (October 24–26, 2023), marking the 150th anniversary of the discovery of the leprosy bacillus by Dr. Gerhard Armauer Hansen.
• Bergen International Film Festival (BIFF)coreStrategic or Co-development PartnerBIFF partnered with the Initiative and University of Bergen to present the world's first international film festival on Hansen's disease (October 2023). BIFF provided venue access, film screenings, and a School Program that screened 'The Last Mile' documentary to 152 students from five high schools.
• Leprosy Museum (Bergen City Museum)coreStrategic or Co-development PartnerThe Leprosy Museum in Bergen, Norway (opened 1970 in St. Jørgen's Hospital, a 15th-century leprosy hospital), partnered with the Initiative for history preservation activities, including the film festival pre-screening event and museum tours during the Bergen conference.
• World Health Organization (WHO)coreStrategic or Co-development PartnerThe WHO–TNF/SHF partnership began in 1975 and marks its 50th anniversary in 2025. TNF/SHF has contributed over $200 million USD to WHO's leprosy elimination efforts. Yohei Sasakawa serves as WHO Goodwill Ambassador for Leprosy Elimination since 2001. WHO and TNF/SHF jointly pursue the Global Leprosy Strategy 2021–2030 toward zero leprosy.
• Sasakawa Health Foundation (SHF)coreStrategic or Co-development PartnerSasakawa Health Foundation is one of the three core entities of the Sasakawa Leprosy Initiative alliance (alongside The Nippon Foundation and the WHO Goodwill Ambassador). SHF administers grant programs, publishes the Leprosy Bulletin, and provides technical and financial support for leprosy elimination activities worldwide.
• Miss Supranational OrganizationminorGTM or Marketing PartnerSasakawa Leprosy Initiative partnered with Miss Supranational for a leprosy awareness campaign in South Sulawesi, Indonesia (2024). Miss Supranational 2024 visited endemic areas to raise awareness and reduce stigma, with a second year of partnership announced in August 2024.
• NLR – until No Leprosy RemainscoreStrategic or Co-development PartnerNLR is an international NGO working on leprosy and neglected tropical diseases. NLR serves as a member of the Global Partnership for Zero Leprosy (GPZL) and collaborated in Bergen International Conference sessions. NLR coordinates with the Initiative on research and advocacy efforts.
• PerMaTa IndonesiacoreStrategic or Co-development PartnerPerMaTa (Persatuan Perhimpunan Masalah Kusta) is the national people's organization of persons affected by leprosy in Indonesia. PerMaTa representatives participate in Initiative events (Bergen Conference, webinars, Global Forums), providing direct testimony and advocacy leadership. PerMaTa South Sulawesi collaborates with YDTI on grassroots projects.
• UN Special Rapporteur on LeprosycoreStrategic or Co-development PartnerThe UN Human Rights Council established the mandate of Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members in 2017. Dr. Alice Cruz held the mandate and participated in Initiative webinars and conferences, contributing to the human rights framework underpinning the Initiative's work.
• Fontilles (Spain)coreStrategic or Co-development PartnerFontilles is a leprosy sanatorium in Spain established in 1909 that remains active as a treatment facility. With SHF funding, Fontilles collaborates with the University of Alicante on a heritage project to preserve the Fontilles Historical Archive and create the 'Fontilles and Leprosy in Spain' portal site.
• Rovisco Pais Hospital (Portugal)minorStrategic or Co-development PartnerRovisco Pais opened in Portugal in 1947 as a self-sufficient hospital colony for leprosy treatment and research. With SHF funding, it preserves cultural heritage through photographic/documentary archives, oral testimonies, museum exhibitions, and the 'Hansen's Stories' website.
• Education International / Japan Teachers' UnioncoreStrategic or Co-development PartnerEducation International (global union of 375 teacher organizations, 33 million+ members) partnered for Global Appeal 2026. Mr. Takashi Kajiwara, Vice President of Education International and President of the Japan Teachers' Union, participated in the launch event, emphasizing science education's role in reducing leprosy stigma.
• ALERT-IndiacoreImplementation/ SI/ Consulting PartnerALERT-India (Association for Leprosy Education Rehabilitation and Treatment) provides technical support for SHF-funded projects. ALERT-India collaborated on the LEAP-HRBA project and subsequent SKSS initiatives in Maharashtra and Gadchiroli districts, supporting data collection and field investigator training.
• Sasakawa-India Leprosy Foundation (S-ILF)Strategic or Co-development PartnerS-ILF is an administrative partner for the Dalai Lama–Sasakawa Education Scholarship, which supports young people from leprosy colonies in India to pursue higher education. S-ILF collaborates on vocational training and coaching programs for children of persons affected by leprosy.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• World Health Organization (WHO): The UN specialized agency for health and the Initiative's core 50-year institutional partner; comparable as a global health governance actor whose strategy-setting, normative guidance, and country-level footprint complement the Initiative's advocacy and grantmaking.
• The Global Fund to Fight AIDS, Tuberculosis and Malaria: Massive multilateral disease-specific financing partnership serving as a structural comparator in the disease-elimination partnership ecosystem; comparable in scale and public-private philanthropic model though focused on different diseases.
• Gavi, the Vaccine Alliance: Public-private global health partnership that channels large-scale philanthropic and government funding to disease-control programs in low-income countries; comparable as a multilateral health alliance with WHO, foundation, and government partners pursuing disease elimination.
• UNICEF: UN agency advancing child and maternal health globally; comparable in scale, UN-system alignment, and country-level health program delivery, though with a broader mandate spanning multiple health and welfare priorities.

Others

• Education International: Global federation of 375 teacher organizations representing 33M+ educators; the Initiative's Global Appeal 2026 co-host and a strategic partner rather than peer, but thematically adjacent as an advocacy-oriented international civil society organization with comparable convening power.
• Bill & Melinda Gates Foundation: Major philanthropic funder of global health, including neglected tropical disease elimination; comparable as a strategic philanthropic counterpart that co-funds the broader global health ecosystem in which the Initiative operates, rather than as a direct leprosy competitor.

Direct peers

• Fontilles: Spanish leprosy foundation and sanatorium founded in 1909, recipient of Sasakawa Health Foundation grants for heritage preservation and treatment; directly comparable as a legacy leprosy NGO combining clinical care, history preservation, and advocacy.
• Damien Foundation: Belgium-based NGO operating leprosy and tuberculosis control programs globally; co-partnered with the Initiative on Global Appeal 2026 in Brussels and brings comparable field implementation experience in disease control and stigma reduction.
• ALERT-India: Indian NGO providing leprosy education, rehabilitation and treatment, an SHF-funded implementation partner for projects in Maharashtra and Gadchiroli; comparable as a country-level leprosy NGO combining field implementation and capacity building.
• NLR – until No Leprosy Remains: International NGO focused on leprosy and neglected tropical diseases, with technical research, advocacy, and country programs highly overlapping the Initiative's mission; co-member of the Global Partnership for Zero Leprosy and collaborator on Bergen Conference sessions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/TNFandSHF
• Facebookfacebook.com/TNFandSHF
• Instagraminstagram.com/sasakawa_leprosy_initiative

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sasakawa Leprosy Initiative